Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | Bora Lim, Rashmi Krishna Murthy, Summer Jackson, Jie S. Willey, Jangsoon Lee, Ricardo H. Alvarez, Carlos Hernando Barcenas, Meghan Sri Karuturi, Nuhad K. Ibrahim, Daniel J. Booser, Stacy L. Moulder, Sharon Hermes Giordano, Abenaa M. Brewster et al | ||||||||||||
Title | Open-label phase Ib study of entinostat (E), and lapatinib (L) alone, and in combination with trastuzumab (T) in patients (pts) with HER2+ metastatic (mHER2+) breast cancer after progression on trastuzumab. | ||||||||||||
|
|||||||||||||
URL | http://abstracts.asco.org/176/AbstView_176_170293.html | ||||||||||||
Abstract Text | J Clin Oncol 34, 2016 (suppl; abstr 609) |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|